Health Technology · Pharmaceuticals: Major · NSE: SUNREST · data 2026-10-09

Sunrest Lifescience Limited

Health check: Strong (7.6/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹36.75

Market cap

₹16 cr

P/E

4.2

P/B

0.8

ROE

22.4%

ROCE

25.9%

Debt / equity

0.85

Dividend yield

0.00%

1-year return

-18.0%

52-week high

₹54

52-week low

₹29.55

Operating margin

11.3%

Growth

Revenue (last 12 months)	₹71 cr
Net profit (last 12 months)	₹4 cr
Sales growth, 3 years (yearly)	43.4%
Profit growth, 3 years (yearly)	26.3%

Similar companies

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) · Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA) · Ortin Global Ltd (ORTINGLOBE)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SUNREST in NSE Scanner →